Amgen (AMGN) Shares Outstanding (Weighted Average) (2009 - 2026)

Amgen has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $540.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.37% year-over-year to $540.0 million; the trailing twelve-month figure through Mar 2026 stood at $540.0 million (changed 0.37% YoY), and the FY2025 full-year result was $538.0 million, changed 0.19% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $540.0 million, roughly flat from $538.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $548.0 million in Q1 2022, with the low at $534.0 million in Q1 2023.
• Average Shares Outstanding (Weighted Average) over 5 years is $537.6 million, with a median of $537.0 million recorded in 2024.
• Year-over-year, Shares Outstanding (Weighted Average) fell 6.47% in 2022 and rose 0.37% in 2024.
• Tracing AMGN's Shares Outstanding (Weighted Average) over 5 years: stood at $538.0 million in 2022, then dropped by 0.56% to $535.0 million in 2023, then rose by 0.37% to $537.0 million in 2024, then gained by 0.19% to $538.0 million in 2025, then grew by 0.37% to $540.0 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $540.0 million (Q1 2026), $538.0 million (Q4 2025), and $538.0 million (Q3 2025), per Business Quant data.

Peer Comparison